Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia Clinical research trials and Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia. Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia clinical trial. Test subjects typically receive the most expert healthcare available for their Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.

Home > "D" Clinical Trials Conditions > Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia

Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia



Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia

For Condition: untreated hairy cell leukemia,progressive hairy cell leukemia, initial treatment,Prolymphocytic Leukemia
Status: Recruiting
Sponsor(s): Swiss Institute for Applied Cancer Research ,
Synopsis: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if giving cladribine once a day is more effective than giving cladribine once a week in patients with hairy cell leukemia. PURPOSE: Randomizedphase III trial to compare the effectiveness of cladribine given once a day to cladribine given once a week in treating patients with hairy cell leukemia.
Details: OBJECTIVES: - Compare the acute hematotoxicity and infection rate with daily and weekly administration of cladribine in patients with hairy cell leukemia. OUTLINE: This is a randomized, multicenter study. Patients are randomized to one of two treatment arms. - Arm I: Patients receive daily subcutaneous bolus injections of cladribine (2-CDA) for 5 days (standard dose). - Arm II: Patients receive weekly subcutaneous bolus injections of 2-CDA for 5 weeks. Patients showing complete or partial remission at evaluation on day 71 of the first treatment course do not receive any further treatment until relapse or disease progression is evident. Patients showing minor or no response on day 71 of the first treatment course receive a subsequent course of standard dose 2-CDA. Patients are followed every 3 months for 2 years, then every 6 months thereafter. PROJECTED ACCRUAL: A total of 120 patients will be accrued for this study within 4 years.
Eligibility:
Study Type:  Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - Histologically confirmed classic form or prolymphocytic variant hairy cell leukemia (HCL) - Newly diagnosed HCL or progressive disease after prior treatment PATIENT CHARACTERISTICS: Age: - 18 and over Performance status: - NCI 0-2 Life expectancy: - At least 3 months Hematopoietic: - Not specified Hepatic: - Bilirubin no greater than 2.0 mg/dL Renal: - Creatinine no greater than 2.3 mg/dL Other: - HIV negative - Not pregnant - No other prior or concurrent malignancy except carcinoma in situ of the cervix or basal or squamous cell carcinoma of the skin PRIOR CONCURRENT THERAPY: - At least 4 weeks since any prior therapy and recovered Biologic therapy: - Not specified Chemotherapy: - No concurrent cytoreductive therapy - No prior cladribine Endocrine therapy: - Not specified Radiotherapy: - Not specified Surgery: - Not specified
Total Enrollment: 

Location and Contact Information:

Overall Study Official:
ReinhardZenhaeusern,  Study Chair,  Inselspital, Bern

Inselspital, Bern *Recruiting*
Bern,  ,  CH-3010
Switzerland
Recruiting Reinhard  Zenhaeusern 41-31-632-4114


Additional Information:
Study ID Numbers:  CDR0000066865;  SWS-SAKK-32/98,EU-98074
Study Start Date: 
Record last reviewed: August 1999
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00003746

Other Untreated Hairy Cell Leukemia Studies:
1. Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia

Related Studies:

Other untreated hairy cell leukemia Clinical Trials
Other Clinical Trials
Other Bern Clinical Trials

Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia
Modify your Search

  Other untreated hairy cell leukemia Clinical Trials
  Other Clinical Trials
  Other Bern Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103